Please complete the CAPTCHA to continue
@neuraltus.com
✓
2 phones found area 650
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
John Whelan is listed as President and CEO at Inhalon Biopharma, Inc. at Inhalon Biopharma, based in Cupertino, California, United States. AeroLeads shows a work email signal at neuraltus.com, phone signal with area code 650, and a matched LinkedIn profile for John Whelan.
John Whelan previously worked as President and CEO at Inhalon Biopharma and President, CFO and COO at Neuraltus Pharmaceuticals. John Whelan holds Mba from Ucla Anderson School Of Management.
This section adds company-level context without repeating John Whelan's masked contact details.
AeroLeads found 1 current-domain work email signal for John Whelan. Compare company email patterns before reaching out.
Public and private company pharmaceutical/biotech executive with twenty years of experience managing life science companies.Successful start-up and turnaround leadership. Work with boards and management to define the company’s vision, create strategic plans, assemble management teams, motivate employees and execute to reach key milestones.Record of creating enterprise value and attracting investors. Increased valuation 40-fold in a turnaround situation. Raised over $240M through public and private equity financings, collaborations and sale of assets. Extensive M&A experience on both buy and sell sides.Hands-on general management skills leading teams in all areas including R&D, Manufacturing/QC/QA, Clinical Operations, FDA Regulatory, Finance, IR/PR, Business Development, Commercial Planning, Legal and Administration.Expertise in biological and small molecule therapeutics, drug delivery systems, discovery platforms, oncology, supportive care and orphan indications.
Listed skills include Start Ups, Biotechnology, Strategy, Mergers And Acquisitions, and 8 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Durham, North Carolina, US
Inhalon Biopharma is developing an inhaled immunotherapy platform for treating acute respiratory infections. The company’s breakthrough enables inhaled antibodies to trap pathogens such as SARS-CoV-2 and RSV in the lung mucus and quickly eliminate them through normal mucus clearance.
San Bruno, CA, US
Developing an anti-neuroinflammatory small molecule for the treatment of Amyotrophic Lateral Sclerosis (Lou Gehrig's disease).
Led the successful turnaround of Heron following receipt of a Complete Response Letter for the company's lead product candidate. Stabilized the company financially and operationally, created a plan to increase company valuation, recruited a new management team, financed operations, addressed FDA issues and prepared for commercialization.
US
Filed Raven’s first Investigational New Drug application for a novel antibody therapeutic. Financed operations through two funding rounds and venture debt. Developed a portfolio of proprietary cell lines and oncology targets and sold the company to Macrogenics with a product in phase 2 clinical development. Recruited experienced executive management team.
Financed company operations through a private financing, debt and the sale of a start-up business operation. Led the process to evaluate strategic combinations, an IPO and sale of the company. Established key partnerships to leverage Eos’ discovery capabilities.
Palo Alto, CA, US
Led strategic acquisitions and collaborations for Hewlett-Packard’s $1.5B medical device and $1B life science instrumentation businesses. Held ascending positions of responsibility and leadership in product management, strategy and marketing in the Computing Systems Group from 1988 to 1996.
Quick answers generated from the profile data available on this page.
John Whelan works for Inhalon Biopharma.
John Whelan is listed as President and CEO at Inhalon Biopharma, Inc. at Inhalon Biopharma.
AeroLeads has found 1 work email signal at @neuraltus.com for John Whelan at Inhalon Biopharma.
AeroLeads has found 2 phone signal(s) with area code 650 for John Whelan at Inhalon Biopharma.
John Whelan is based in Cupertino, California, United States while working with Inhalon Biopharma.
John Whelan has worked for Inhalon Biopharma, Neuraltus Pharmaceuticals, Heron Therapeutics, Inc. (Fka A.P. Pharma), Raven Biotechnologies (Acquired By Macrogenics), and Eos Biotechnology (Acquired By Pdl Biopharma).
You can use AeroLeads to view verified contact signals for John Whelan at Inhalon Biopharma, including work email, phone, and LinkedIn data when available.
John Whelan holds Mba from Ucla Anderson School Of Management.
John Whelan is listed with skills including Start Ups, Biotechnology, Strategy, Mergers And Acquisitions, Lifesciences, Clinical Development, Oncology, and Business Development.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts